Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01609868 · ClinicalTrials.gov registry record · NA
The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01609868 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 60 participants.
The verdict
NCT01609868, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.
Interventions
- DIETARY_SUPPLEMENT Powder protein modular
- DIETARY_SUPPLEMENT Liquid protein modular
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01609868
The ClinicalTrials.gov registry entry for NCT01609868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Powder protein modular is the first listed.
NCT01609868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01609868 about?
NCT01609868 is a clinical study titled "The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU". The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.
What is the current status of trial NCT01609868?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01609868?
The interventions under investigation include: Powder protein modular (DIETARY_SUPPLEMENT), Liquid protein modular (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01609868?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.